Fig. 1From: Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s diseaseSample selection from ADNI. 3438 MRI were available from participants, 74 of them failed quality control, ending up to 3364 available scans to study. Similarly, 3758 participants had available results from plasma ptau181. Combined together, we had 2869 available scans and plasma pTau181 results which dates of assessment were within 6 monthsBack to article page